IMAX CORP·4

Apr 28, 4:15 PM ET

GELFOND RICHARD L 4

Research Summary

AI-generated summary

Updated

IMAX CEO Richard Gelfond Exercises Options and Sells 8,943 Shares

What Happened
Richard L. Gelfond, CEO of IMAX (IMAX), exercised stock options to convert 8,943 derivative shares into common stock at $31.40 per share (cost basis $280,810) and immediately sold those 8,943 shares in the open market at $37.33 per share, realizing $333,814. The transactions were executed on April 27, 2026 and reported on Form 4.

Key Details

  • Transaction date: 2026-04-27 (Form 4 filed 2026-04-28 — timely filing).
  • Exercise/conversion: 8,943 shares acquired at $31.40 each — total acquisition value $280,810.
  • Sale: 8,943 shares sold at $37.33 each — total proceeds $333,814.
  • Footnotes: Exercise and sale were made pursuant to a 10b5-1 plan dated December 9, 2025; sales under that plan are now complete. Options were originally issued in 2016 and expire June 7, 2026. The options vested in 2016 (installments in June, September and December 2016).
  • Holdings after the transactions: options outstanding 1,332,411; restricted share units 231,562; common shares 765,002.

Context
This was an option exercise followed by an immediate sale under a prearranged 10b5-1 plan (a cashless-like transaction). Such filings are commonly routine (liquidity or option-exercise driven) and do not, by themselves, indicate management sentiment about the company. The exercised options were from a 2016 grant that is nearing its June 7, 2026 expiration, which can be a practical reason for exercising before expiry.